Page last updated: 2024-12-08

2-nitrophenyl-beta-fucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-nitrophenyl-beta-fucoside: RN given refers to (beta-D-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID150889
CHEBI ID44419
SCHEMBL ID2544558
MeSH IDM0136007

Synonyms (21)

Synonym
2-nitrophenyl beta-d-fucopyranoside
orthonitrophenyl-beta-d-fucopyranoside
1154-94-5
CHEBI:44419
2-nitrophenyl 6-deoxy-beta-d-galactopyranoside
onpf
2-nitrophenyl beta-d-fucoside
2-nitrophenyl-beta-d-fucopyranoside
DB08297
o-nitrophenyl beta-d-fucopyranoside
(2r,3r,4s,5r,6s)-2-methyl-6-(2-nitrophenoxy)oxane-3,4,5-triol
2-nitrophenyl 6-deoxyhexopyranoside
2-nitrophenyl-beta-fucoside
beta-d-galactopyranoside, 2-nitrophenyl 6-deoxy-
12624-08-7
AKOS015918200
SCHEMBL2544558
(2r,3r,4s,5r,6s)-2-methyl-6-(2-nitrophenoxy)tetrahydro-2h-pyran-3,4,5-triol
DTXSID80921729
Q2928817
AMY41687
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
beta-D-fucoside
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.59 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]